1. Home
  2. VERU vs ABAT Comparison

VERU vs ABAT Comparison

Compare VERU & ABAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • ABAT
  • Stock Information
  • Founded
  • VERU 1971
  • ABAT 2011
  • Country
  • VERU United States
  • ABAT United States
  • Employees
  • VERU N/A
  • ABAT N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • ABAT Metal Mining
  • Sector
  • VERU Health Care
  • ABAT Basic Materials
  • Exchange
  • VERU Nasdaq
  • ABAT Nasdaq
  • Market Cap
  • VERU 76.9M
  • ABAT 87.2M
  • IPO Year
  • VERU 1990
  • ABAT N/A
  • Fundamental
  • Price
  • VERU $0.50
  • ABAT $1.32
  • Analyst Decision
  • VERU Strong Buy
  • ABAT
  • Analyst Count
  • VERU 2
  • ABAT 0
  • Target Price
  • VERU $4.00
  • ABAT N/A
  • AVG Volume (30 Days)
  • VERU 856.5K
  • ABAT 2.4M
  • Earning Date
  • VERU 05-08-2025
  • ABAT 05-16-2025
  • Dividend Yield
  • VERU N/A
  • ABAT N/A
  • EPS Growth
  • VERU N/A
  • ABAT N/A
  • EPS
  • VERU N/A
  • ABAT N/A
  • Revenue
  • VERU $16,886,419.00
  • ABAT $1,857,877.00
  • Revenue This Year
  • VERU N/A
  • ABAT $31,748.62
  • Revenue Next Year
  • VERU N/A
  • ABAT N/A
  • P/E Ratio
  • VERU N/A
  • ABAT N/A
  • Revenue Growth
  • VERU 134.43
  • ABAT N/A
  • 52 Week Low
  • VERU $0.45
  • ABAT $0.73
  • 52 Week High
  • VERU $1.42
  • ABAT $4.11
  • Technical
  • Relative Strength Index (RSI)
  • VERU 44.61
  • ABAT 48.83
  • Support Level
  • VERU $0.48
  • ABAT $1.25
  • Resistance Level
  • VERU $0.56
  • ABAT $1.62
  • Average True Range (ATR)
  • VERU 0.02
  • ABAT 0.14
  • MACD
  • VERU -0.00
  • ABAT -0.03
  • Stochastic Oscillator
  • VERU 30.83
  • ABAT 18.92

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About ABAT American Battery Technology Company

American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.

Share on Social Networks: